FAHIM RAAFAT E F 4
4 · NABI BIOPHARMACEUTICALS · Filed Jan 7, 2011
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Sale
Common Stock
2011-01-05$5.65/sh−3,181$17,973→ 330,637.941 total
Footnotes (1)
- [F1]This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.